Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer

BJU International

Volumn 107, Issue 10, 2011, Pages 1668-1675

  Rink, Michael ^a   Chun, Felix K H ^a   Minner, Sarah ^a   Friedrich, Martin ^a   Mauermann, Oliver ^a   Heinzer, Hans ^b   Huland, Hartwig ^b   Fisch, Margit ^a   Pantel, Klaus ^a   Riethdorf, Sabine ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Helios Hospital Krefeld   (Germany)

Author keywords

bladder cancer; CellSearch TM System; circulating tumour cells; CTC; immunomagnetic capture

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER CANCER; BLOOD SAMPLING; CANCER CELL; CANCER GROWTH; CANCER SURVIVAL; CELL COUNT; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; EARLY DETECTION OF CANCER; EPIDEMIOLOGIC METHODS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOMAGNETIC SEPARATION; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; URINARY BLADDER NEOPLASMS;

EID: 79955438082     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09562.x     Document Type: Article

References (43)

1. Jemal A, Siegel R, Ward E, et al,. Cancer statistics, 2008. CA Cancer J Clin 2008; 58 (2): 71-96 (Pubitemid 351521864)
2. Stein JP, Lieskovsky G, Cote R, et al,. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19 (3): 666-75 (Pubitemid 32120143)
3. Loberg RD, Fridman Y, Pienta BA, et al,. Detection and isolation of circulating tumor cells in urologic cancers: a review. Neoplasia 2004; 6 (4): 302-9 (Pubitemid 38924845)
4. Nezos A, Pissimisis N, Lembessis P, et al,. Detection of circulating tumor cells in bladder cancer patients. Cancer Treat Rev 2009; 35 (3): 272-9
5. Cristofanilli M, Budd GT, Ellis MJ, et al,. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004; 351 (8): 781-91 (Pubitemid 39095313)
6. Allard WJ, Matera J, Miller MC, et al,. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004; 10 (20): 6897-904 (Pubitemid 39383039)
7. de Bono JS, Scher HI, Montgomery RB, et al,. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 2008; 14 (19): 6302-9
8. Riethdorf S, Fritsche H, Muller V, et al,. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 2007; 13 (3): 920-8 (Pubitemid 46340368)
9. Naoe M, Ogawa Y, Morita J, et al,. Detection of circulating urothelial cancer cells in the blood using the CellSearch System. Cancer 2007; 109 (7): 1439-45 (Pubitemid 46466573)
10. Karl A, Tritschler S, Hofmann S, Stief CG, Schindlbeck C,. Perioperative search for circulating tumor cells in patients undergoing radical cystectomy for bladder cancer. Eur J Med Res 2009; 14 (11): 487-90
11. Baeuerle PA, Gires O,. EpCAM (CD326) finding its role in cancer. Br J Cancer 2007; 96 (3): 417-23 (Pubitemid 46215211)
12. Balzar M, Winter MJ, de Boer CJ, Litvinov SV,. The biology of the 17-1A antigen (Ep-CAM). J Mol Med 1999; 77 (10): 699-712
13. Brunner A, Prelog M, Verdorfer I, et al,. EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinoma of the bladder. J Clin Pathol 2008; 61 (3): 307-10 (Pubitemid 351354235)
14. Gupta A, Lotan Y, Bastian PJ, et al,. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy. Urology 2008; 71 (2): 302-7 (Pubitemid 351282384)
15. Pantel K, Alix-Panabieres C, Riethdorf S,. Cancer micrometastases. Nat Rev Clin Oncol 2009; 6 (6): 339-51
16. Shaffer DR, Leversha MA, Danila DC, et al,. Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer. Clin Cancer Res 2007; 13 (7): 2023-9 (Pubitemid 46649868)
17. Budd GT, Cristofanilli M, Ellis MJ, et al,. Circulating tumor cells versus imaging-predicting overall survival in metastatic breast cancer. Clin Cancer Res 2006; 12 (21): 6403-9 (Pubitemid 44799711)
18. Hayes DF, Cristofanilli M, Budd GT, et al,. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 2006; 12 (14 Pt 1): 4218-24
19. Pantel K, Brakenhoff RH, Brandt B,. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 2008; 8 (5): 329-40 (Pubitemid 351596394)
20. Jimenez RE, Gheiler E, Oskanian P, et al,. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol 2000; 24 (7): 980-7 (Pubitemid 30430485)
21. Guzzo TJ, McNeil BK, Bivalacqua TJ, et al,. The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy. Urol Oncol 2009 [Epub ahead of print]
22. Gallagher DJ, Milowsky MI, Ishill N, et al,. Detection of circulating tumor cells in patients with urothelial cancer. Ann Oncol 2009; 20 (2): 305-8
23. Sastre J, Maestro ML, Puente J, et al,. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol 2008; 19 (5): 935-8 (Pubitemid 351627310)
24. Moreno JG, Miller MC, Gross S, et al,. Circulating tumor cells predict survival in patients with metastatic prostate cancer. Urology 2005; 65 (4): 713-8 (Pubitemid 40523005)
25. Naoe M, Ogawa Y, Takeshita K, Iwamoto S, Miyazaki A,. Use of the CellSearch Circulating Tumor Cell Test for monitoring urothelial cancer: two case reports of metastatic urothelial cancer. South Med J 2008; 101 (4): 439-41 (Pubitemid 351507523)
26. Tibbe AG, Miller MC, Terstappen LW,. Statistical considerations for enumeration of circulating tumor cells. Cytometry A 2007; 71 (3): 154-62 (Pubitemid 46355340)
27. Bassi P, Ferrante GD, Piazza N, et al,. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. J Urol 1999; 161 (5): 1494-7 (Pubitemid 29420803)
28. Harada K, Sakai I, Hara I, Eto H, Miyake H,. Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy. Int J Urol 2005; 12 (3): 250-5 (Pubitemid 40646696)
29. Leissner J, Koeppen C, Wolf HK,. Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy. J Urol 2003; 169 (3): 955-60 (Pubitemid 36188133)
30. Dawood S, Broglio K, Valero V, et al,. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system? Cancer 2008; 113 (9): 2422-30
31. Hiraiwa K, Takeuchi H, Hasegawa H, et al,. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol 2008; 15 (11): 3092-100
32. Stenzl A, Cowan NC, De Santis M, et al. The updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer. Eur Urol 2009; 55 (4): 815-25
33. Alix-Panabieres C, Riethdorf S, Pantel K,. Circulating tumor cells and bone marrow micrometastasis. Clin Cancer Res 2008; 14 (16): 5013-21
34. Jung R, Kruger W, Hosch S, et al,. Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. Br J Cancer 1998; 78 (9): 1194-8 (Pubitemid 28479150)
35. Sleijfer S, Gratama JW, Sieuwerts AM, et al,. Circulating tumour cell detection on its way to routine diagnostic implementation? Eur J Cancer 2007; 43 (18): 2645-50 (Pubitemid 350151847)
36. Fehm T, Sagalowsky A, Clifford E, et al,. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 2002; 8 (7): 2073-84 (Pubitemid 34753576)
37. Marches R, Scheuermann R, Uhr J,. Cancer dormancy: from mice to man. Cell Cycle 2006; 5 (16): 1772-8 (Pubitemid 44435319)
38. Meng S, Tripathy D, Frenkel EP, et al,. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 2004; 10 (24): 8152-62 (Pubitemid 40053373)
39. Sieuwerts AM, Kraan J, Bolt J, et al,. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 2009; 101 (1): 61-6
40. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T,. Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer 2005; 5 (9): 744-9 (Pubitemid 41486367)
41. Christofori G,. New signals from the invasive front. Nature 2006; 441 (7092): 444-50 (Pubitemid 44050139)
42. Schmidt H, DeAngelis G, Eltze E, et al,. Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN gene. Cancer Res 2006; 66 (18): 8959-65 (Pubitemid 44521111)
43. Attard G, Swennenhuis JF, Olmos D, et al,. Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer. Cancer Res 2009; 69 (7): 2912-8